CVS Health Corp (NYSE:CVS) Shares Sold by Endurance Wealth Management Inc.

Endurance Wealth Management Inc. cut its stake in CVS Health Corp (NYSE:CVS) by 2.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 25,398 shares of the pharmacy operator’s stock after selling 689 shares during the quarter. Endurance Wealth Management Inc.’s holdings in CVS Health were worth $1,602,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Baldwin Brothers Inc. MA grew its stake in shares of CVS Health by 1.1% during the third quarter. Baldwin Brothers Inc. MA now owns 14,911 shares of the pharmacy operator’s stock valued at $941,000 after buying an additional 165 shares during the last quarter. Mutual Advisors LLC grew its stake in shares of CVS Health by 0.8% during the second quarter. Mutual Advisors LLC now owns 20,641 shares of the pharmacy operator’s stock valued at $1,125,000 after buying an additional 172 shares during the last quarter. Fiduciary Group LLC grew its stake in shares of CVS Health by 3.2% during the second quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock valued at $353,000 after buying an additional 200 shares during the last quarter. Legacy Advisors LLC grew its stake in shares of CVS Health by 2.5% during the third quarter. Legacy Advisors LLC now owns 8,048 shares of the pharmacy operator’s stock valued at $508,000 after buying an additional 200 shares during the last quarter. Finally, Carlton Hofferkamp & Jenks Wealth Management LLC grew its stake in shares of CVS Health by 1.5% during the third quarter. Carlton Hofferkamp & Jenks Wealth Management LLC now owns 13,255 shares of the pharmacy operator’s stock valued at $824,000 after buying an additional 201 shares during the last quarter. 76.17% of the stock is owned by hedge funds and other institutional investors.

In other news, EVP Troyen A. Brennan sold 23,604 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $68.00, for a total transaction of $1,605,072.00. Following the completion of the sale, the executive vice president now owns 107,921 shares of the company’s stock, valued at approximately $7,338,628. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Eva C. Boratto sold 8,130 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $65.00, for a total transaction of $528,450.00. Following the sale, the chief financial officer now directly owns 55,273 shares of the company’s stock, valued at approximately $3,592,745. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 49,437 shares of company stock valued at $3,248,811. 0.53% of the stock is owned by company insiders.

Shares of CVS stock traded up $0.69 during trading hours on Friday, hitting $72.47. 9,079,719 shares of the company’s stock traded hands, compared to its average volume of 6,966,567. CVS Health Corp has a 12-month low of $51.72 and a 12-month high of $82.15. The stock has a market cap of $87.55 billion, a price-to-earnings ratio of 10.24, a PEG ratio of 1.46 and a beta of 0.86. The stock’s fifty day simple moving average is $64.66 and its two-hundred day simple moving average is $58.54. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.07. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The company had revenue of $64.81 billion during the quarter, compared to analyst estimates of $62.99 billion. During the same period in the previous year, the business earned $1.73 EPS. The firm’s revenue for the quarter was up 36.5% on a year-over-year basis. On average, equities analysts forecast that CVS Health Corp will post 6.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 4th. Investors of record on Thursday, October 24th were issued a $0.50 dividend. The ex-dividend date was Wednesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.76%. CVS Health’s payout ratio is currently 28.25%.

Several analysts recently issued reports on CVS shares. SunTrust Banks raised their target price on CVS Health to $85.00 and gave the stock a “buy” rating in a research note on Thursday. Wells Fargo & Co raised their target price on CVS Health from $62.00 to $72.00 and gave the stock a “market perform” rating in a research note on Friday. Bank of America raised their target price on CVS Health from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Thursday, September 12th. Deutsche Bank started coverage on CVS Health in a research note on Thursday, September 12th. They issued a “buy” rating and a $91.00 target price on the stock. Finally, Cowen set a $76.00 target price on CVS Health and gave the stock a “buy” rating in a research note on Monday, October 21st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $77.59.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: Percentage Decliners

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News